FLI1
Summary: This gene encodes a transcription factor containing an ETS DNA-binding domain. The gene can undergo a t(11;22)(q24;q12) translocation with the Ewing sarcoma gene on chromosome 22, which results in a fusion gene that is present in the majority of Ewing sarcoma cases. An acute lymphoblastic leukemia-associated t(4;11)(q21;q23) translocation involving this gene has also been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| Fli-1 proto-oncogene, ETS transcription factor | MIM:193067 | Ensembl:ENSG00000151702 | HGNC:HGNC:3749 | PA28170 | 11q24.3 |
GO terms in FLI1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0006357 | regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0006366 | transcription by RNA polymerase II |
| BP | TAS | GO:0007599 | hemostasis |
| BP | IEA | GO:0008015 | blood circulation |
| BP | IEA | GO:0009887 | animal organ morphogenesis |
| BP | IBA | GO:0030154 | cell differentiation |
| BP | IEA | GO:0035855 | megakaryocyte development |
| BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IEA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
| CC | IDA | GO:0005829 | cytosol |
| CC | IDA | GO:0016604 | nuclear body |
| MF | IEA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
| MF | IEA | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding |
| MF | IBA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | ISM | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | NAS | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IEA | GO:0001077 | transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding |
| MF | TAS | GO:0003677 | DNA binding |
| MF | IEA | GO:0003682 | chromatin binding |
| MF | TAS | GO:0003700 | DNA-binding transcription factor activity |
| MF | IPI | GO:0005515 | protein binding |
Gene expression in normal tissue: FLI1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in FLI1
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP2849 | Hematopoietic Stem Cell Differentiation |
| kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD151 | CHM-1 | 3 |
| iGMDRD144 | NSC95397 | 3 |
| iGMDRD546 | BMS-754807 | 1 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD193 | Fqi1 | 4 |
| iGMDRD394 | BX-795 | 2 |
| iGMDRD280 | CYTOCHALASIN B | 2 |
| iGMDRD679 | Bistramide A | 1 |
| iGMDRD298 | L-685458 | 3 |
| iGMDRD260 | FQI-2 | 3 |
| iGMDRD870 | BRD63610 | 3 |
| iGMDRD887 | Compound 23 citrate | 3 |
| iGMDRD506 | Fedratinib | 2 |
| iGMDRD398 | Sepantronium | 3 |
| iGMDRD780 | PP-30 | 2 |
| iGMDRD562 | Navitoclax | 2 |
| iGMDRD64 | Parbendazole | 3 |
| iGMDRD60 | Quinoclamine | 2 |
| iGMDRD23 | Gossypol | 3 |
| iGMDRD307 | Manumycin A | 3 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD424 | Tamatinib | 3 |
| iGMDRD523 | Cyanoquinoline, 11 | 3 |
| iGMDRD701 | NVP-AUY922 | 3 |
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD341 | Triacsin c | 2 |
| iGMDRD698 | Neratinib | 3 |
| iGMDRD219 | Bax channel blocker | 3 |
| iGMDRD901 | ELCPK | 6 |
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD883 | CIL55A | 3 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD121 | GMX1778 | 3 |
| iGMDRD202 | Curcumin | 3 |
| iGMDRD705 | Nakiterpiosin | 3 |
| iGMDRD434 | BMS-536924 | 7 |
| iGMDRD267 | Oligomycin A | 2 |
| iGMDRD414 | MST-312 | 5 |
| iGMDRD871 | BRD6368 | 3 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD872 | BRD7137 | 2 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD886 | Compound 1541A | 3 |
| iGMDRD505 | Pevonedistat | 6 |
| iGMDRD263 | AACOCF3 | 2 |
| iGMDRD322 | FK 866 | 6 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in FLI1

